Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.17 Analyst target: $1.50 Upside: 806.34%
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.